Login

Syngene International Ltd.

₹695.1

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Syngene International Ltd.

₹695.1

₹695.1

-2.0 (-0.29%) - 8 Apr 2025 04:25 PM

About Company

Syngene International Limited, incorporated in 1993, is an internationally reputed contract research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. The company’s multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The company has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. The company’s animal facilities are GLP certified by the Indian authorities and AAALAC accredited.

Market Cap. ₹28,061 Cr.
52 Week - High/Low ₹961/608
P/E Ratio 57.85
P/B Ratio 6.69
Enterprise Value ₹28,027 Cr.
ROE % 12.07
RSI Value 45.01
EMA 50 727.69
EMA 200 778.6
Net Profit 466 Cr.
Net Profit 3year growth 15.56 Cr.
Net Profit 3 year (back) 404 Cr.
Debt to Equity 0.03 %
EPS Growth TTM 3.79 %
Current Ratio 1.69 %
100 Day SMA 790 Rs.
200 Day SMA 812 Rs.
21 Day SMA 703 Rs.
50 Day SMA 712 Rs.
Book Value 104 Rs.
EV/EBITDA Ratio 28
QoQ EPS Growth 27 %
QoQ Operating Profit Growth 22 %
QoQ Sales Growth 7 %
Sales Latest Quarter 877 Cr.
YoY Sales Growth 11 %
Market Cap. ₹28,061 Cr.
52 Week - High/Low ₹961/608
P/E Ratio 55.77
P/B Ratio 6.59
Enterprise Value ₹28,206 Cr.
ROE % 13.18
RSI Value 45.01
EMA 50 727.69
EMA 200 778.6
Net Profit 510 Cr.
Net Profit 3year growth -0.56 Cr.
Net Profit 3 year (back) 405 Cr.
Debt to Equity 0.03 %
EPS Growth TTM 0.24 %
Current Ratio 1.71 %
100 Day SMA 790 Rs.
200 Day SMA 812 Rs.
21 Day SMA 703 Rs.
50 Day SMA 712 Rs.
Book Value 106 Rs.
EV/EBITDA Ratio 25
QoQ EPS Growth 24 %
QoQ Operating Profit Growth 17 %
QoQ Sales Growth 6 %
Sales Latest Quarter 944 Cr.
YoY Sales Growth 11 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.